Diabetes

A molecule known as LXA4 could serve as a potential treatment for heart disease caused by diabetes.

New understanding of the impact of gestational diabetes on infant growth revealed.

Novel findings pave the way for new diabetes treatments.

Study finds link between diabetes diagnosis at young age and dementia risk.

In 2023, semaglutide emerged as the top-selling drug in the USA, generating $13.8 billion in sales.

New research shows that diabetes rates have doubled to 800 million adults, but over half remain untreated.

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related hospitalisations.

The researchers found that overeating triggers a rapid increase in norepinephrine, a key stress hormone. This, in turn, over activates the sympathetic nervous system.